共 155 条
[1]
Austin CP(2004)Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development Neuroscience 124 3-10
[2]
Ky B(2016)Re-conceptualizing ASD within a dimensional framework: positive, negative, and cognitive feature clusters J Autism Dev Disord 46 342-351
[3]
Ma L(2016)Global economic burden of schizophrenia: a systematic review Neuropsychiatr Dis Treat 12 357-373
[4]
Morris JA(2015)Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics Am J Health Syst Pharm 72 378-389
[5]
Shughrue PJ(2010)The paradox of premature mortality in schizophrenia: new research questions J Psychopharmacol 24 9-15
[6]
Foss-Feig JH(2016)The economic burden of schizophrenia in the United States in 2013 J Clin Psychiatry 77 764-771
[7]
McPartland JC(2003)Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997–2000 MedGenMed 5 16-264
[8]
Anticevic A(2004)Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors Schizophr Bull 30 255-598
[9]
Wolf J(2020)Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis CNS Drugs 34 579-218
[10]
Chong HY(2013)Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review Ther Adv Psychopharmacol 3 200-62